Veracyte director sells $80K in company stock

A Veracyte director sold a small block of shares under a pre-arranged Rule 10b5-1 trading plan and continues to hold over forty thousand shares.

Rhea-AI Filing Summary

VERACYTE, INC. (VCYT) director Muna Bhanji reported selling 1,864 shares of common stock on September 1, 2026 at a price of $42.97 per share in an open-market or private transaction. After this sale, Bhanji directly holds 42,718 shares. The sale was made under a pre-arranged Rule 10b5-1 trading plan adopted on June 2, 2026.

Insider Trade Summary 10b5-1

Net Seller: 1,864 shares

Net Sell 1 txn

Insider Bhanji Muna

Role Director

Sold 1,864 shs ($80K)

Type	Security	Shares	Price	Value
Sale	Common Stock F1	1,864	$42.97	$80K

Holdings After Transaction: Common Stock — 42,718 shares (Direct)

Footnotes (1)

1. F1. The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 2, 2026.

Key Figures

Shares sold: 1,864 shares Sale price per share: $42.97 per share Total transaction value: $80,096.08 +1 more

4 metrics

Shares sold 1,864 shares Common stock sold by director on September 1, 2026

Sale price per share $42.97 per share Price for the 1,864 shares of common stock sold

Total transaction value $80,096.08 Approximate value of 1,864 shares sold at $42.97 per share

Shares held after transaction 42,718 shares Director’s direct holdings following the sale

Key Terms

Rule 10b5-1 plan, open market or private transaction, reporting person

3 terms

Rule 10b5-1 plan regulatory

"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan"

A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.

open market or private transaction market

"Sale in open market or private transaction"

reporting person regulatory

"plan adopted by the reporting person on June 2, 2026"

FAQ

What insider transaction did VERACYTE, INC. (VCYT) disclose in this Form 4?

VERACYTE, INC. disclosed that director Muna Bhanji sold 1,864 shares of common stock on September 1, 2026 in an open-market or private transaction at $42.97 per share, and now directly holds 42,718 shares.

At what price were the VCYT shares sold by the director?

The reported sale by director Muna Bhanji involved 1,864 VCYT shares at a price of $42.97 per share on September 1, 2026, described as a sale in an open-market or private transaction.

How many VERACYTE (VCYT) shares does the director own after this transaction?

After the reported sale, director Muna Bhanji directly owns 42,718 shares of VERACYTE, INC. common stock, as disclosed in the Form 4 following the September 1, 2026 transaction.

Was the VCYT insider sale made under a Rule 10b5-1 trading plan?

Yes. The Form 4 states that the reported transactions were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 2, 2026, indicating the sales were pre-arranged under that plan.

What is the total value of the VCYT shares sold by the director?

Based on the reported sale of 1,864 shares at $42.97 per share, the total transaction value is approximately $80,096.08, reflecting the gross value of the shares sold on September 1, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/03/2026 - 05:00 PM Accepted by SEC EDGAR 09/03/2026 - 04:48 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bhanji Muna

(Last) (First) (Middle)

6000 SHORELINE COURT

SUITE 300

(Street)

SOUTH SAN FRANCISCO CALIFORNIA 94080

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
VERACYTE, INC. [ VCYT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/01/2026		S(1)		1,864	D	$42.97	42,718	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 2, 2026.

Remarks:

	/s/ Jonathan Wygant as attorney-in-fact	09/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)